Literature DB >> 27661757

Sepsis-induced acute kidney injury.

Hernando Gómez1, John A Kellum.   

Abstract

PURPOSE OF REVIEW: Sepsis is a common and frequently fatal condition in which mortality has been consistently linked to increasing organ dysfunction. For example, acute kidney injury (AKI) occurs in 40-50% of septic patients and increases mortality six to eight-fold. However, the mechanisms by which sepsis causes organ dysfunction are not well understood and hence current therapy remains reactive and nonspecific. RECENT
FINDINGS: Recent studies have challenged the previous notion that organ dysfunction is solely secondary to hypoperfusion, by showing, for example, that AKI occurs in the setting of normal or increased renal blood flow; and that it is characterized not by acute tubular necrosis or apoptosis, but rather by heterogeneous areas of colocalized sluggish peritubular blood flow and tubular epithelial cell oxidative stress. Evidence has also shown that microvascular dysfunction, inflammation, and the metabolic response to inflammatory injury are fundamental pathophysiologic mechanisms that may explain the development of sepsis-induced AKI.
SUMMARY: The implications of these findings are significant because in the context of decades of negative clinical trials in the field, the recognition that other mechanisms are at play opens the possibility to better understand the processes of injury and repair, and provides an invaluable opportunity to design mechanism-targeted therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27661757      PMCID: PMC5654474          DOI: 10.1097/MCC.0000000000000356

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  75 in total

Review 1.  A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury.

Authors:  Hernando Gomez; Can Ince; Daniel De Backer; Peter Pickkers; Didier Payen; John Hotchkiss; John A Kellum
Journal:  Shock       Date:  2014-01       Impact factor: 3.454

2.  Molecular links between autophagy and apoptosis.

Authors:  Iwona A Ciechomska; Christoph G Goemans; Aviva M Tolkovsky
Journal:  Methods Mol Biol       Date:  2008

3.  Microvascular and interstitial oxygen tension in the renal cortex and medulla studied in a 4-h rat model of LPS-induced endotoxemia.

Authors:  Alex Dyson; Rick Bezemer; Matthieu Legrand; Gianmarco Balestra; Mervyn Singer; Can Ince
Journal:  Shock       Date:  2011-07       Impact factor: 3.454

4.  Nitroglycerin in septic shock after intravascular volume resuscitation.

Authors:  Peter E Spronk; Can Ince; Martin J Gardien; Keshen R Mathura; Heleen M Oudemans-van Straaten; Durk F Zandstra
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

5.  Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study.

Authors:  Eric A J Hoste; Sean M Bagshaw; Rinaldo Bellomo; Cynthia M Cely; Roos Colman; Dinna N Cruz; Kyriakos Edipidis; Lui G Forni; Charles D Gomersall; Deepak Govil; Patrick M Honoré; Olivier Joannes-Boyau; Michael Joannidis; Anna-Maija Korhonen; Athina Lavrentieva; Ravindra L Mehta; Paul Palevsky; Eric Roessler; Claudio Ronco; Shigehiko Uchino; Jorge A Vazquez; Erick Vidal Andrade; Steve Webb; John A Kellum
Journal:  Intensive Care Med       Date:  2015-07-11       Impact factor: 17.440

Review 6.  Selective iNOS inhibition for the treatment of sepsis-induced acute kidney injury.

Authors:  Suzanne Heemskerk; Rosalinde Masereeuw; Frans G M Russel; Peter Pickkers
Journal:  Nat Rev Nephrol       Date:  2009-09-29       Impact factor: 28.314

7.  Acute renal failure during sepsis: potential role of cell cycle regulation.

Authors:  Quan-Hui Yang; Da-Wei Liu; Yun Long; Hong-Zhong Liu; Wen-Zhao Chai; Xiao-Ting Wang
Journal:  J Infect       Date:  2009-04-17       Impact factor: 6.072

Review 8.  Sepsis-Induced Acute Kidney Injury.

Authors:  Johan Mårtensson; Rinaldo Bellomo
Journal:  Crit Care Clin       Date:  2015-07-29       Impact factor: 3.598

9.  Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery.

Authors:  Melanie Meersch; Christoph Schmidt; Hugo Van Aken; Sven Martens; Jan Rossaint; Kai Singbartl; Dennis Görlich; John A Kellum; Alexander Zarbock
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

10.  Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.

Authors:  Kianoush Kashani; Ali Al-Khafaji; Thomas Ardiles; Antonio Artigas; Sean M Bagshaw; Max Bell; Azra Bihorac; Robert Birkhahn; Cynthia M Cely; Lakhmir S Chawla; Danielle L Davison; Thorsten Feldkamp; Lui G Forni; Michelle Ng Gong; Kyle J Gunnerson; Michael Haase; James Hackett; Patrick M Honore; Eric A J Hoste; Olivier Joannes-Boyau; Michael Joannidis; Patrick Kim; Jay L Koyner; Daniel T Laskowitz; Matthew E Lissauer; Gernot Marx; Peter A McCullough; Scott Mullaney; Marlies Ostermann; Thomas Rimmelé; Nathan I Shapiro; Andrew D Shaw; Jing Shi; Amy M Sprague; Jean-Louis Vincent; Christophe Vinsonneau; Ludwig Wagner; Michael G Walker; R Gentry Wilkerson; Kai Zacharowski; John A Kellum
Journal:  Crit Care       Date:  2013-02-06       Impact factor: 9.097

View more
  83 in total

1.  ZEB2 Attenuates LPS-Induced Inflammation by the NF-κB Pathway in HK-2 Cells.

Authors:  Qi Ding; Yang Wang; Ai-Ling Zhang; Tao Xu; Dan-Dan Zhou; Xiao-Feng Li; Jun-Fa Yang; Lei Zhang; Xiao Wang
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

2.  Lysophosphatidic Acid Protects Against Endotoxin-Induced Acute Kidney Injury.

Authors:  Koryun Mirzoyan; Colette Denis; Audrey Casemayou; Marion Gilet; Dimitri Marsal; Dominique Goudounéche; Stanislas Faguer; Jean-Loup Bascands; Joost P Schanstra; Jean-Sébastien Saulnier-Blache
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

Review 3.  A review of the role of immune cells in acute kidney injury.

Authors:  Anthony Bonavia; Kai Singbartl
Journal:  Pediatr Nephrol       Date:  2017-08-11       Impact factor: 3.714

Review 4.  Acute kidney injury in sepsis.

Authors:  Rinaldo Bellomo; John A Kellum; Claudio Ronco; Ron Wald; Johan Martensson; Matthew Maiden; Sean M Bagshaw; Neil J Glassford; Yugeesh Lankadeva; Suvi T Vaara; Antoine Schneider
Journal:  Intensive Care Med       Date:  2017-03-31       Impact factor: 17.440

5.  A simple risk score for prediction of sepsis associated-acute kidney injury in critically ill patients.

Authors:  Jiaojiao Zhou; Yajun Bai; Xin Wang; Jia Yang; Ping Fu; Dingming Cai; Lichuan Yang
Journal:  J Nephrol       Date:  2019-07-16       Impact factor: 3.902

6.  Pterostilbene attenuates acute kidney injury in septic mice.

Authors:  Yizi Xia; Ying Chen; Luming Tang; Zheng Wang; Yu Zheng
Journal:  Exp Ther Med       Date:  2018-01-30       Impact factor: 2.447

7.  NMR-based serum and urine metabolomic profile reveals suppression of mitochondrial pathways in experimental sepsis-associated acute kidney injury.

Authors:  Stephen W Standage; Shenyuan Xu; Lauren Brown; Qing Ma; Adeleine Koterba; Patrick Lahni; Prasad Devarajan; Michael A Kennedy
Journal:  Am J Physiol Renal Physiol       Date:  2021-04-12

8.  A novel risk-predicted nomogram for sepsis associated-acute kidney injury among critically ill patients.

Authors:  Shanglin Yang; Tingting Su; Lina Huang; Lu-Huai Feng; Tianbao Liao
Journal:  BMC Nephrol       Date:  2021-05-10       Impact factor: 2.388

9.  Impaired angiotensin II type 1 receptor signaling contributes to sepsis-induced acute kidney injury.

Authors:  Daniel E Leisman; Tiago D Fernandes; Vanesa Bijol; Mabel N Abraham; Jake R Lehman; Matthew D Taylor; Christine Capone; Omar Yaipan; Rinaldo Bellomo; Clifford S Deutschman
Journal:  Kidney Int       Date:  2020-08-31       Impact factor: 10.612

Review 10.  The application of omic technologies to research in sepsis-associated acute kidney injury.

Authors:  Denise Hasson; Stuart L Goldstein; Stephen W Standage
Journal:  Pediatr Nephrol       Date:  2020-04-30       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.